DE Judge Dismisses Lilly Suit Against AZ Pharmacy Compounder

By Gabrielle Wanneh / October 9, 2025 at 5:31 PM

A Delaware district court on Wednesday (Oct. 8) dismissed Eli Lilly’s legal challenge against Strive Pharmacy, thwarting another effort by the brand drug company to stop compounding pharmacies from producing and selling compounded versions of tirzepatide, the active ingredient of its popular the company’s diabetes drug Mounjaro and weight-loss treatment Zepbound.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.